Also trades as: VANIW (OTC)
VANI NASDAQ
Vivani Medical, Inc.
1W: -8.4%
1M: +9.2%
3M: -5.8%
YTD: +3.1%
1Y: -18.6%
3Y: +2.3%
5Y: -88.7%
$1.31
+0.01 (+0.77%)
Weekly Expected Move ±13.8%
$1
$1
$1
$1
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$10.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$113.0M
52W Range0.923-1.92
Volume218,432
Avg Volume475,533
Beta3.29
Dividend—
Analyst Ratings
Company Info
CEOAdam Mendelsohn
Employees42
SectorHealthcare
IndustryBiotechnology
IPO Date2014-11-19
Websitevivani.com
1350 S. Loop Road
Alameda, CA 94608
US
Alameda, CA 94608
US
818 833 5000
About Vivani Medical, Inc.
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.
Latest News
Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité
Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung
Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139
Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139
Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BRADBURY DANIEL | A-Award | 7,965 | $1.30 | 2026-07-27 |
| Williams Gregg | P-Purchase | 793,650 | $1.26 | 2026-07-15 |
| Moretti August J | A-Award | 36,000 | $1.22 | 2026-06-24 |
| Moretti August J | 0 | — | 2026-06-24 | |
| Williams Gregg | A-Award | 36,516 | $1.22 | 2026-06-24 |